Average Co-Inventor Count = 7.43
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Nuvation Bio Inc. (18 from 18 patents)
2. Medivation Technologies, Inc. (6 from 63 patents)
3. Auransa Inc. (1 from 6 patents)
25 patents:
1. 12398121 - Anti-cancer nuclear hormone receptor-targeting compounds
2. 12208141 - Anti-cancer nuclear hormone receptor-targeting compounds
3. 12006314 - Anti-cancer nuclear hormone receptor-targeting compounds
4. 11952349 - Anti-cancer nuclear hormone receptor-targeting compounds
5. 11834458 - Anti-cancer nuclear hormone receptor-targeting compounds
6. 11826430 - Anti-cancer nuclear hormone receptor-targeting compounds
7. 11702401 - Compounds and methods of use
8. 11584756 - Heterocyclic compounds as BET inhibitors
9. 11485725 - Derivatives of piperlongumine and uses thereof
10. 11332473 - Substituted pyrazolo[3,4-d]pyrimidines as Wee1 inhibitors
11. 11306071 - Heterocyclic compounds as adenosine antagonists
12. 11299493 - Heterocyclic compounds and uses thereof
13. 11292782 - Diarylhydantoin compounds and methods of use thereof
14. 11254670 - 1,8-naphthyridinone compounds and uses thereof
15. 11192900 - Substituted 1,6-dihydropyridinones and 1,2-dihydroisoquinolinones as bet inhibitors